Galectin-1 mediated suppression of Epstein-Barr virus–specific T-cell immunity in classic Hodgkin lymphoma
Open Access
- 15 August 2007
- journal article
- Published by American Society of Hematology in Blood
- Vol. 110 (4) , 1326-1329
- https://doi.org/10.1182/blood-2007-01-066100
Abstract
In Hodgkin lymphoma (HL), the malignant Hodgkin Reed-Sternberg cells interact with the host microenvironment to create an immunosuppressive network tKeywords
This publication has 24 references indexed in Scilit:
- Galectin-1: a key effector of regulation mediated by CD4+CD25+ T cellsBlood, 2006
- Expression of LAG-3 by tumor-infiltrating lymphocytes is coincident with the suppression of latent membrane antigen–specific CD8+ T-cell function in Hodgkin lymphoma patientsBlood, 2006
- Technology Insight: applications of emerging immunotherapeutic strategies for Epstein–Barr virus-associated malignanciesNature Clinical Practice Oncology, 2005
- Galectin-1 induces nuclear translocation of endonuclease G in caspase- and cytochrome c-independent T cell deathCell Death & Differentiation, 2004
- Epstein–Barr virus‐associated Hodgkin's lymphomaBritish Journal of Haematology, 2004
- Hodgkin’s Lymphoma: Evolving Concepts with Implications for PracticeHematology-American Society Hematology Education Program, 2004
- Ex Vivo Analysis of T-Cell Responses to Epstein-Barr Virus-Encoded Oncogene Latent Membrane Protein 1 Reveals Highly Conserved Epitope Sequences in Virus Isolates from Diverse Geographic RegionsJournal of Virology, 2003
- The role of cytokines in classical Hodgkin lymphomaBlood, 2002
- A Prognostic Score for Advanced Hodgkin's DiseaseNew England Journal of Medicine, 1998
- HUMAN CYTOTOXIC T LYMPHOCYTE RESPONSES TO EPSTEIN-BARR VIRUS INFECTIONAnnual Review of Immunology, 1997